11/02/2026
**IMPORTANT WOMEN'S HEALTH ISSUE**
In January, Australian pharmaceutical company Lawley Pharmaceuticals launched legal action against the Pharmaceutical Benefits Advisory Committee (PBAC) after its decision not to recommend PBS listing of AndroFeme 1 — a female-specific testosterone treatment for post-menopausal women with distressing low libido.
This is a pivotal moment.
Why this matters
Testosterone plays a meaningful role in sexual wellbeing for some post-menopausal women, particularly those living with hypoactive sexual desire dysfunction (HSDD).
Yet in Australia:
• Men have access to at least eight PBS-subsidised testosterone products
• Women have access to none
As a result, women prescribed testosterone currently pay 14–16 times more than men for equivalent treatment — putting care out of reach for many.
AndroFeme 1 is:
• The only female-specific testosterone formulation of its kind worldwide
• Approved for use in Australia, the UK, New Zealand, and South Africa
• TGA-registered since 2020, but only available privately in Australia
If listed on the PBS, it would significantly reduce cost and improve equitable access for women who need it.
Why I am speaking up
I see this every day in my clinic, community and clinical education.
• Women are told their symptoms “don’t matter enough”
• Evidence-based treatments are labelled “non-essential”
• Cost becomes a barrier to care — again and again
This case is not just about one product.
It’s about whether women’s sexual health, quality of life, and equity in menopause care are taken seriously.
What you can do
I'm asking our community, both public and professional, to stand together.
Sign the petition calling for fair PBS access to testosterone for women.
By signing, you'll:
• Stay updated as the case progresses
• Be the first to hear about advocacy opportunities
• Help strengthen a united voice for equitable menopause care
Change in women’s health has never come quietly. It comes because people speak up, together.
Thank you for being part of a community that believes women deserve better.
Pip x
Give Women Access to Affordable Testosterone Treatment: Put AndroFeme on the PBS